发明名称 Medicament for influencing intra=ocular pressure and treating myopia - comprises cells isolated from the iris of vertebrate(s)
摘要 Medicament for influencing intraocular pressure comprises components (I) of (C) Kogan egg cells. Isolation of ascorbic acid (II), (I) or a halocrine incretion (III) from the eyes up vertebrates comprises: (a) either sepg. the front quarter of the eyeball (consisting of the iris, the cornea, the aq. humour and a part of the lens) from the rest of the eyeball, or making an incision in the cornea; (b) removing the iris and the aq. humour; (c) squeezing out the tissue fluids in the iris/aq. humour, to give (III) (which contains (I)) and (I) (which is present in the aq. humour. USE/ADVANTAGE - Esp. used for treatment of progressive short-sightedness in young people and elevated ocular pressure in older people
申请公布号 DE4207366(A1) 申请公布日期 1993.04.08
申请号 DE19924207366 申请日期 1992.03.05
申请人 OBAL, ADALBERT, DR.MED., 1000 BERLIN, DE 发明人 OBAL, ADALBERT, DR.MED., 1000 BERLIN, DE
分类号 A61K35/44 主分类号 A61K35/44
代理机构 代理人
主权项
地址